Advanced prostate cancer

Guidelines:Prostate cancer/Management/Locally advanced and metastatic/Metastatic/Bisphosphonates

From Cancer Guidelines Wiki
Clinical practice guidelines for the management of locally advanced and metastatic prostate cancer > Guidelines:Prostate cancer/Management/Locally advanced and metastatic/Metastatic/Bisphosphonates


Guideline contents > Metastatic

Clinical practice guidelines for the management of locally advanced and metastatic prostate cancer

Funding received from
PCFA VER 2COL PMS.png AALogo Tagline nobg.png

  Cite this page

Cancer Council Australia Advanced Prostate Cancer Guidelines Working Party. Guidelines:Prostate cancer/Management/Locally advanced and metastatic/Metastatic/Bisphosphonates . In: Clinical practice guidelines for the management of locally advanced and metastatic prostate cancer. Sydney: Cancer Council Australia. [Version URL: https://wiki.cancer.org.au/australiawiki/index.php?oldid=65431, cited 2023 Dec 11]. Available from: https://wiki.cancer.org.au/australia/Guidelines:Prostate_cancer/Management/Locally_advanced_and_metastatic.


Last modified:
12 September 2013 06:53:06




Bisphosphonates

No recommendations have been made for hormone naïve metastatic disease. See What is the evidence for the use of bisphosphonates in the prevention of skeletal events? for a discussion of a single trial of bisphononates for hormone-naïve metastatic bone disease.

Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Guidelines:Prostate_cancer/Management/Locally_advanced_and_metastatic/Metastatic/Bisphosphonates&oldid=65431"